cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target
- PMID: 26004537
- PMCID: PMC4534343
- DOI: 10.1016/j.pt.2015.04.014
cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target
Abstract
Despite recent research linking cAMP signalling to virulence in trypanosomatids and detailed studies of trypanosomatid adenylyl cyclases (ACs) and phosphodiesterases (PDEs) since their discoveries 40 years ago, downstream components of the pathway and their biological functions have remained remarkably elusive. However, in recent years, significant discoveries have been made: a role for parasite ACs has been proposed in cytokinesis, evasion of the host immune response, and social motility. cAMP phosphodiesterases PDEB1 and PDEB2 were found to be essential for survival and virulence of Trypanosoma brucei and, in Trypanosoma cruzi, PDEC2 was shown to be required for normal osmoregulation. As we discuss here, these breakthroughs have led to an ongoing surge in the development of PDE inhibitors as lead compounds for trypanocidal drugs.
Keywords: adenylyl cyclases; cAMP; drug target; phosphodiesterases; trypanosomatids.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures


Similar articles
-
cAMP signalling in the kinetoplastid protozoa.Curr Mol Med. 2004 Sep;4(6):585-99. doi: 10.2174/1566524043360113. Curr Mol Med. 2004. PMID: 15357210 Review.
-
Phosphodiesterase regulation of alcohol drinking in rodents.Alcohol. 2015 Dec;49(8):795-802. doi: 10.1016/j.alcohol.2015.03.007. Epub 2015 May 29. Alcohol. 2015. PMID: 26095589 Free PMC article. Review.
-
cAMP signalling in Trypanosoma brucei.Int J Parasitol. 2001 May 1;31(5-6):491-8. doi: 10.1016/s0020-7519(01)00164-3. Int J Parasitol. 2001. PMID: 11334934 Review.
-
The adenylate cyclase UvAc1 and phosphodiesterase UvPdeH control the intracellular cAMP level, development, and pathogenicity of the rice false smut fungus Ustilaginoidea virens.Fungal Genet Biol. 2019 Aug;129:65-73. doi: 10.1016/j.fgb.2019.04.017. Epub 2019 May 4. Fungal Genet Biol. 2019. PMID: 31063805
-
Signal Transduction Pathways as Therapeutic Target for Chagas Disease.Curr Med Chem. 2019;26(36):6572-6589. doi: 10.2174/0929867326666190620093029. Curr Med Chem. 2019. PMID: 31218950 Review.
Cited by
-
Cyclic Nucleotide-Specific Phosphodiesterases as Potential Drug Targets for Anti-Leishmania Therapy.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00603-18. doi: 10.1128/AAC.00603-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30104270 Free PMC article.
-
Nutrient sensing in Leishmania: Flagellum and cytosol.Mol Microbiol. 2021 May;115(5):849-859. doi: 10.1111/mmi.14635. Epub 2020 Nov 21. Mol Microbiol. 2021. PMID: 33112443 Free PMC article. Review.
-
Large-Scale Phylogenetic Analysis of Trypanosomatid Adenylate Cyclases Reveals Associations with Extracellular Lifestyle and Host-Pathogen Interplay.Genome Biol Evol. 2020 Dec 6;12(12):2403-2416. doi: 10.1093/gbe/evaa226. Genome Biol Evol. 2020. PMID: 33104188 Free PMC article.
-
Frequent Recombination Events in Leishmania donovani: Mining Population Data.Pathogens. 2020 Jul 15;9(7):572. doi: 10.3390/pathogens9070572. Pathogens. 2020. PMID: 32679679 Free PMC article.
-
International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.Pharmacol Rev. 2017 Apr;69(2):93-139. doi: 10.1124/pr.116.013078. Pharmacol Rev. 2017. PMID: 28255005 Free PMC article. Review.
References
-
- Kennedy P.G. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness) Lancet Neurol. 2013;12:186–194. - PubMed
-
- Nunes M.C. Chagas disease: an overview of clinical and epidemiological aspects. J. Am. Coll. Cardiol. 2013;62:767–776. - PubMed
-
- Salman S.M. Cutaneous leishmaniasis: clinical features and diagnosis. Clin. Dermatol. 1999:291–296. - PubMed
-
- Georgiadou S.P. Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece. Int. J. Infect. Dis. 2015;34:46–50. - PubMed
-
- Kedzierski L. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr. Med. Chem. 2009;16:599–614. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials